骨质疏松性胸腰椎压缩性骨折PKP术后再骨折危险因素分析

张军; 刘培太; 吴硕柱; 张军; 刘培太; 吴硕柱

doi:10.13898/j.cnki.issn.1000-2200.2019.08.021

[1]

李军, 吴家昌, 蒋勇, 等.椎体成形术与椎体后凸成形术治疗椎体压缩性骨折疗效的Meta分析[J].中国矫形外科杂志, 2014, 22(8):696. doi: 10.3977/j.issn.1005-8478.2014.08.06

[2]

BLASCO J, MARTINEZ-FERRER A, MACHO J, et al.Effect of vertebroplasty on pain relief, quality of life, and the incidence of new vertebral fractures:a 12-month randomized follow-up controlled trial[J].J Bone Mineral Res, 2012, 27(5):1159. doi: 10.1002/jbmr.1564

[3]

KIM JH, YOO SH, KIM JH.Long-term follow-up of percutaneous vertebroplasty in osteo-porotic compression fracture:minimum of 5 years follow-up[J].Asian Spine J, 2012, 6(1):6. doi: 10.4184/asj.2012.6.1.6

[4]

LEE WS, SUNG KH, JEONG HT, et al.Risk factors of developing new symptomatic vertebral compression fractures after percutaneous vertebroplasty in osteoporotic patients[J].Eur Spine J, 2011, 15(12):1777.

[5]

朱书涛, 刘洋, 张明辉, 等.PKP术后患者再骨折危险因素分析[J].中国矫形外科杂志, 2016, 24(16):1445.

[6]

李仁波, 尚静波, 姜丽.PKP治疗骨质疏松性压缩骨折后椎体再骨折的原因分析[J].大连医科大学学报, 2018, 40(1):43.

[7]

马树伟, 吴继功, 马华松, 等.PKP治疗急性期及亚急性期椎体压缩骨折的效果分析[J].河北医科大学学报, 2018, 39(3):280. doi: 10.3969/j.issn.1007-3205.2018.03.008

[8]

李小宏, 张有为, 刘列, 等.PKP和PVP治疗骨质疏松性椎体压缩骨折的疗效比较[J].临床骨科杂志, 2018, 21(2):150. doi: 10.3969/j.issn.1008-0287.2018.02.009

[9]

黄文显, 邓颂波, 曾日祥, 等.PVP和PKP治疗骨质疏松性椎体压缩骨折临床随机对照研究[J].泰山医学院学报, 2019, 40(1):41. doi: 10.3969/j.issn.1004-7115.2019.01.012

[10]

李智斐, 付拴虎, 张家立, 等.椎体成形术后再骨折相关因素分析[J].中国脊柱脊髓杂志, 2014, 24(9):790. doi: 10.3969/j.issn.1004-406X.2014.09.05

[11]

YOO CM, PARK KB, HWANG SH, et al.The analysis of patterns and risk factors of newly developed vertebral compression fractures after percutaneous vertebroplasty[J].J Korean Neurosurg Soc, 2012, 52(4):339. doi: 10.3340/jkns.2012.52.4.339

[12]

RHO YJ, CHOE WJ, Chun YI.Risk factors predicting the new symptomatic vertebral compression fractures after percutaneous vertebroplasty or kyphoplasty[J].Eur Spine J, 2012, 21(5):905. doi: 10.1007/s00586-011-2099-5

[13]

彭冉东, 邓强, 李中锋, 等.骨质疏松性椎体压缩骨折PKP术后近期手术椎体再骨折原因探讨[J].实用骨科杂志, 2017, 23(9):781.

[14]

李格, 梅伟, 刘沛霖, 等.骨质疏松性椎体压缩骨折经皮椎体成形术后邻近椎体再骨折的危险因素探讨[J].中医正骨, 2016, 28(6):18.

[15]

王芳芳, 刘红正, 王拴池, 等.PVP术后手术强化椎再骨折因素分析[J].西部医学, 2018, 30(8):1150. doi: 10.3969/j.issn.1672-3511.2018.08.013

[16]

林森, 陈小强, 周涛, 等.骨质疏松性椎体压缩性骨折椎体成形术后再骨折的影响因素分析[J].中华临床医师杂志, 2016, 10(12):1670. doi: 10.3877/cma.j.issn.1674-0785.2016.12.003

[17]

吴鹏, 王博, 刘康, 等.唑来膦酸钠对高转换患者椎体成形术后椎体再骨折发生率影响因素的相关性分析[J].中国骨质疏松杂志, 2017, 23(8):1075. doi: 10.3969/j.issn.1006-7108.2017.08.021

[18]

段学会.椎体成形结合抗骨质疏松治疗减少再骨折发生率的可行性研究[J].青岛医药卫生, 2018, 50(1):32. doi: 10.3969/j.issn.1006-5571.2018.01.011